Globus Medical, Inc. (GMED)

NYSE: GMED · Real-Time Price · USD

74.29

+0.21 (0.28%)

At close: Sep 21, 2026, 4:00 PM EDT

74.29

0.00 (0.00%)

After-hours: Sep 21, 2026, 4:15 PM EDT

Globus Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	9,974	11,685	11,262	7,343	7,415	7,326
Market Cap Growth	31.36%	3.76%	53.38%	-0.97%	1.22%	13.84%
Enterprise Value	9,246	11,398	11,092	7,122	6,506	6,347
Last Close Price	74.08	87.31	82.71	53.29	74.27	72.20

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	19.00	21.73	109.36	59.76	38.99	49.11
Forward PE	14.56	21.59	25.54	20.76	32.74	33.48
PS Ratio	3.17	3.98	4.47	4.68	7.25	7.65
PB Ratio	2.09	2.56	2.70	1.84	4.02	4.21
P/TBV Ratio	3.78	4.88	5.78	4.48	4.68	4.91
P/FCF Ratio	13.19	19.85	27.79	44.44	71.01	33.40
P/OCF Ratio	10.95	15.51	21.63	30.16	41.55	26.52
PEG Ratio	1.17	1.51	1.82	1.81	2.71	3.26

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.94	3.88	4.40	4.54	6.36	6.62
EV/EBITDA Ratio	9.14	13.00	15.97	17.00	21.30	23.97
EV/EBIT Ratio	12.65	18.99	25.15	26.04	27.44	32.57
EV/FCF Ratio	12.23	19.36	27.37	43.11	62.31	28.93

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.02	0.03	0.13	0.13	0.00	-
Debt / EBITDA Ratio	0.11	0.13	0.75	1.19	0.02	-
Debt / FCF Ratio	0.15	0.20	1.33	3.16	0.06	-
Net Debt / Equity Ratio	-0.15	-0.11	-0.10	-0.02	-0.51	-0.58
Net Debt / EBITDA Ratio	-0.72	-0.58	-0.60	-0.17	-3.06	-3.80
Net Debt / FCF Ratio	-0.96	-0.87	-1.03	-0.44	-8.96	-4.58
Asset Turnover	0.60	0.56	0.49	0.44	0.51	0.53
Inventory Turnover	1.23	1.32	1.09	0.83	0.98	1.03
Quick Ratio	2.78	2.61	1.72	2.61	4.17	4.35
Current Ratio	4.62	4.26	2.54	4.88	6.18	6.17
Return on Equity (ROE)	11.81%	12.29%	2.52%	4.21%	10.60%	9.19%
Return on Assets (ROA)	8.74%	7.11%	5.33%	4.77%	7.35%	6.70%
Return on Invested Capital (ROIC)	13.93%	13.41%	9.61%	7.51%	13.72%	13.53%
Return on Capital Employed (ROCE)	14.60%	12.50%	10.00%	5.80%	12.40%	10.70%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.37%	4.60%	0.91%	1.67%	2.56%	2.04%
FCF Yield	7.58%	5.04%	3.60%	2.25%	1.41%	2.99%
Buyback Yield / Dilution	1.18%	0.58%	-20.27%	-11.68%	0.95%	-2.63%

SEC Filings: 10-K · 10-Q